Prognostic Nutritional Index
The Prognostic Nutritional Index (PNI) is an immunonutritional clinical metric that reflects aspects of a patient’s nutritional and immune status using routinely available blood-test data.
The Prognostic Nutritional Index (PNI) is an immunonutritional clinical metric that reflects aspects of a patient’s nutritional and immune status using routinely available blood-test data. It is used primarily for risk stratification rather than as a therapeutic target, and has been investigated alongside markers such as the Glasgow Prognostic Score, C-reactive protein–albumin–lymphocyte index, neutrophil-to-lymphocyte ratio, systemic inflammation response index, systemic immune-inflammation index, and geriatric nutritional risk index.
Recent studies have evaluated PNI in diverse clinical settings, including gastrointestinal, pancreatic, esophageal, colorectal, and oral cancers; osteosarcoma; renal transplantation; neonatal cholestasis; psychiatric illness; and postoperative care in older adults with hip fractures. Reported applications include estimating survival, recurrence-related outcomes, postoperative delirium, treatment completion, and acute renal allograft rejection. In gastrointestinal surgery, PNI has also been incorporated into composite prognostic tools, including a symptom-tumor-nutrition score in which a PNI of 40 or lower contributed one risk point. Although these findings support its association with disease prognosis and treatment course, differing populations, study designs, and thresholds limit direct comparison and do not establish that PNI itself is causally responsible for clinical outcomes.
Where the papers sit
9 papers from the last 6 months study Prognostic Nutritional Index directly · updated from PubMed 3 Nov 2026
Study type 0 clinical trials · 8 observational · 1 human data
Themes one subject
Those 9 are all about one subject.
-
Immunonutritional Risk Assessment
Inflammatory and nutritional indices are being evaluated as accessible predictors of treatment completion, postoperative complications, delirium, and long-term survival. PNI recurs across gastric, esophageal, colorectal, oral, and renal-transplant settings, while SIRI, SII, GNRI, the CRP-albumin-lymphocyte index, and GPS broaden the biomarker panel. Associations generally link poorer nutritional status and greater inflammation with worse outcomes, but the strongest index varies by disease and endpoint. Evidence remains observational and context-specific, leaving prospective validation and clinical thresholds unresolved.
Papers
The 9 papers from the last 6 months that study Prognostic Nutritional Index directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Immunonutritional Risk Assessment (9)
- Preoperative Prognostic Nutritional Index Predicts Long-term Outcomes After Curative Gastrectomy for Gastric Cancer. Anticancer research · 1 Oct 2026 PMID 42823166
- Association of Pretreatment Absolute Neutrophil Count and Prognostic Nutritional Index With Completion of Neoadjuvant Gemcitabine Plus S-1 in Resectable Pancreatic Cancer. Anticancer research · 1 Oct 2026 PMID 42823160
- SIRI, SII, and PNI in psychiatric patients with positive urinary drug metabolites: association with immune and nutritional biomarkers. BMC psychiatry · 4 Sept 2026 PMID 42693429
- Complete blood count-derived inflammatory biomarkers and neonatal cholestasis in preterm infants: a matched case-control study. European journal of pediatrics · 3 Sept 2026 PMID 42686933
- Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
- C-Reactive Protein-Albumin-Lymphocyte Index, Prognostic Nutritional Index, and Glasgow Prognostic Score as Predictors of Acute Renal Allograft Rejection: A Comparative Analysis. Transplantation proceedings · 21 Aug 2026 PMID 42629277
- A Preoperative Symptom-tumor-nutrition Score Predicting Survival After Laparoscopic Resection for Colorectal Cancer. Anticancer research · 29 Jul 2026 PMID 42527097
- Clinical Value of Pre-treatment Immunonutritional Indices in T4 Esophageal Cancer Treated With Radiotherapy. Anticancer research · 29 Jun 2026 PMID 42373276
- Association between preoperative prognostic nutritional index and postoperative delirium in older adults with hip fractures: a real-world study. Annals of medicine · 22 Jun 2026 PMID 42329416
By study type
Observational studies and case reports (8)
- Preoperative Prognostic Nutritional Index Predicts Long-term Outcomes After Curative Gastrectomy for Gastric Cancer. Anticancer research · 1 Oct 2026 PMID 42823166
- Association of Pretreatment Absolute Neutrophil Count and Prognostic Nutritional Index With Completion of Neoadjuvant Gemcitabine Plus S-1 in Resectable Pancreatic Cancer. Anticancer research · 1 Oct 2026 PMID 42823160
- SIRI, SII, and PNI in psychiatric patients with positive urinary drug metabolites: association with immune and nutritional biomarkers. BMC psychiatry · 4 Sept 2026 PMID 42693429
- Complete blood count-derived inflammatory biomarkers and neonatal cholestasis in preterm infants: a matched case-control study. European journal of pediatrics · 3 Sept 2026 PMID 42686933
- C-Reactive Protein-Albumin-Lymphocyte Index, Prognostic Nutritional Index, and Glasgow Prognostic Score as Predictors of Acute Renal Allograft Rejection: A Comparative Analysis. Transplantation proceedings · 21 Aug 2026 PMID 42629277
- A Preoperative Symptom-tumor-nutrition Score Predicting Survival After Laparoscopic Resection for Colorectal Cancer. Anticancer research · 29 Jul 2026 PMID 42527097
- Clinical Value of Pre-treatment Immunonutritional Indices in T4 Esophageal Cancer Treated With Radiotherapy. Anticancer research · 29 Jun 2026 PMID 42373276
- Association between preoperative prognostic nutritional index and postoperative delirium in older adults with hip fractures: a real-world study. Annals of medicine · 22 Jun 2026 PMID 42329416
Human data, design not indexed (1)
- Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-10-03. Drafted by language models from published abstracts; not medical advice.